Dr Rajnikant R Patel, MD | |
1520 Slate Creek Rd, Grundy, VA 24614-6975 | |
(276) 935-6444 | |
(276) 935-1875 |
Full Name | Dr Rajnikant R Patel |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 1520 Slate Creek Rd, Grundy, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609845874 | NPI | - | NPPES |
4356476 | Other | VI | AETNA |
0106040000 | Medicaid | WV | |
64661366 | Medicaid | KY | |
010039932 | Medicaid | VA | |
453693 | Other | VA | ANTHEM BCBS OF VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 0101027849 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Rajnikant R Patel, MD 1520 Slate Creek Rd, Grundy, VA 24614-6975 Ph: (276) 935-6444 | Dr Rajnikant R Patel, MD 1520 Slate Creek Rd, Grundy, VA 24614-6975 Ph: (276) 935-6444 |
News Archive
NPR reports that rescission, "where health insurance companies cancel policies after people run up heavy bills" is one of the points of agreement among lawmakers of both parties in health care reform as evidenced by its inclusion in comments at last week's health care summit.
An analysis of data from 2005 through 2008 of nine metropolitan areas in the U.S. indicates that health care-associated invasive methicillin-resistant Staphylococcus aureus infections decreased among patients with infections that began in the community or in the hospital, according to a study in the August 11 issue of JAMA.
The longer immigrants live in the United States, the more likely they are to use prescription opioids-a fact that contradicts popular views linking wealth and health, and suggests that American culture is uniquely favorable toward prescribing opioids.
Regulation of a single, specific gene in a brain region related to drug addiction and depression is sufficient to reduce drug and stress responses, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published October 27 online in the journal Nature Neuroscience.
Illumina, Inc. today announced that Verinata Health, an Illumina company, has published the first peer-reviewed study of non-invasive prenatal test (NIPT) performance in a clinical laboratory setting.
› Verified 5 days ago